APA aipamena

Bates, J. T., Keefer, C. J., Slaughter, J. C., Kulp, D. W., Schiefd, W. R., & Crowe, J. E. (2014). Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein.

Chicago Style aipamena

Bates, John T., Christopher J. Keefer, James C. Slaughter, Daniel W. Kulp, William R. Schiefd, and James E. Crowe. Escape From Neutralization By the Respiratory Syncytial Virus-specific Neutralizing Monoclonal Antibody Palivizumab Is Driven By Changes in On-rate of Binding to the Fusion Protein. 2014.

MLA aipamena

Bates, John T., et al. Escape From Neutralization By the Respiratory Syncytial Virus-specific Neutralizing Monoclonal Antibody Palivizumab Is Driven By Changes in On-rate of Binding to the Fusion Protein. 2014.